Terms: = Kidney tumors AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Diagnosis
3691 results:
1. Contrast-Enhanced Ultrasound as a Diagnostic Procedure in Renal Diseases: A Case Report.
Sellitto S; Tarantino L; Barone F; Barone N; Perna A; Lucariello A; Guerra G; De Luca A; Filippelli A; Sellitto C
G Ital Nefrol; 2024 Apr; 41(2):. PubMed ID: 38695227
[TBL] [Abstract] [Full Text] [Related]
2. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
[TBL] [Abstract] [Full Text] [Related]
3. Management of Nontraumatic Spontaneous Renal Hemorrhage (Wünderlich Syndrome) through Robotic-Assisted Laparoscopic Nephrectomy: A Case Series.
Tao B; Zhang H; Zhang G; Liu H; Meng L; Zhu X; Ji X; Jia G; Qi A; Wang C
Am J Case Rep; 2024 Apr; 25():e942826. PubMed ID: 38659203
[TBL] [Abstract] [Full Text] [Related]
4. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
Nakanishi S; Goya M; Suda T; Yonamine T; Sugawa A; Saito S
BMC Urol; 2024 Apr; 24(1):94. PubMed ID: 38658967
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
[TBL] [Abstract] [Full Text] [Related]
6. Safety of Docetaxel in a Patient with Metastatic Castration-Resistant Prostate Cancer After kidney Transplantation: A Case Report.
Nagahisa C; Iizuka J; Kobari Y; Minoda R; Oki R; Unagami K; Yoshida K; Hirai T; Omoto K; Shimizu T; Ishida H; Takagi T
Transplant Proc; 2024 Apr; 56(3):729-733. PubMed ID: 38548511
[TBL] [Abstract] [Full Text] [Related]
7. National clinical and financial outcomes associated with acute kidney injury following esophagectomy for cancer.
Ng AP; Chervu N; Branche C; Bakhtiyar SS; Marzban M; Toste PA; Benharash P
PLoS One; 2024; 19(3):e0300876. PubMed ID: 38547215
[TBL] [Abstract] [Full Text] [Related]
8. Characteristics of high frame frequency contrast-enhanced ultrasound in renal tumors.
Zhang W; Wang J; Chen L
BMC Med Imaging; 2024 Mar; 24(1):71. PubMed ID: 38528467
[TBL] [Abstract] [Full Text] [Related]
9. The effect of pregnancy on renal angiomyolipoma; a world of knowledge to gain, specifically in women with TSC.
Kluiving MW; Peeters EFHI; Lely TA; van Oorschot N; de Ranitz-Greven WL
BMC Nephrol; 2024 Mar; 25(1):113. PubMed ID: 38519911
[TBL] [Abstract] [Full Text] [Related]
10. Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
Ribelles N; Pascual J; Galvez-Carvajal L; Ruiz-Medina S; Garcia-Corbacho J; Benitez JC; Dominguez-Recio ME; Torres E; Oliva L; Zalabardo M; Rueda A; Alba E
JCO Glob Oncol; 2024 Mar; 10():e2300363. PubMed ID: 38513186
[TBL] [Abstract] [Full Text] [Related]
11. Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study.
Baard J; Cormio L; Dasgupta R; Maruzzi D; Rais-Bahrami S; Serrano A; Geavlete B; Giannakopoulos S; de la Rosette J; Laguna P
World J Urol; 2024 Mar; 42(1):177. PubMed ID: 38507109
[TBL] [Abstract] [Full Text] [Related]
12. Focus on Upper Urinary Tract Stones Combined with Parenchymal Infiltrative Renal Pelvis Cancer.
Zhang Y; Ke Y; Qiu AX; Yang B; Shen C; Wen LJ; Xu XL; Yu Y; Wang W
Kidney Blood Press Res; 2024; 49(1):228-238. PubMed ID: 38471493
[TBL] [Abstract] [Full Text] [Related]
13. Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study.
Munshi L; Dumas G; Rochwerg B; Shoukat F; Detsky M; Fergusson DA; Ferreyro BL; Heffernan P; Herridge M; Magder S; Minden M; Patel R; Qureshi S; Schimmer A; Thyagu S; Wang HT; Mehta S
Intensive Care Med; 2024 Apr; 50(4):561-572. PubMed ID: 38466402
[TBL] [Abstract] [Full Text] [Related]
14. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
[TBL] [Abstract] [Full Text] [Related]
15. A Rare Case of Donor-Derived Renal Cell Carcinoma in a kidney Transplant Recipient.
Sebastian W; Omar KO; Anees R; Nagaraju S; Chaitanya M
Am J Case Rep; 2024 Mar; 25():e941214. PubMed ID: 38442088
[TBL] [Abstract] [Full Text] [Related]
16. OPTN/SRTR 2022 Annual Data Report: Liver.
Kwong AJ; Kim WR; Lake JR; Schladt DP; Schnellinger EM; Gauntt K; McDermott M; Weiss S; Handarova DK; Snyder JJ; Israni AK
Am J Transplant; 2024 Feb; 24(2S1):S176-S265. PubMed ID: 38431359
[TBL] [Abstract] [Full Text] [Related]
17. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Siva S; Bressel M; Sidhom M; Sridharan S; Vanneste BGL; Davey R; Montgomery R; Ruben J; Foroudi F; Higgs B; Lin C; Raman A; Hardcastle N; Hofman MS; De Abreu Lourenco R; Shaw M; Mancuso P; Moon D; Wong LM; Lawrentschuk N; Wood S; Brook NR; Kron T; Martin J; Pryor D;
Lancet Oncol; 2024 Mar; 25(3):308-316. PubMed ID: 38423047
[TBL] [Abstract] [Full Text] [Related]
18. Multiple cutaneous and uterine leiomyomatosis: Reed's syndrome.
Bhanja DB; Sil A; Sikder B; Chandra A
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417936
[TBL] [Abstract] [Full Text] [Related]
19. Ultrasound image segmentation of renal tumors based on UNet++ with fusion of multiscale residuals and dual attention.
Qi H; Wang Z; Qi X; Shi Y; Xie T
Phys Med Biol; 2024 Mar; 69(7):. PubMed ID: 38412532
[No Abstract] [Full Text] [Related]
20. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
[Next]
